Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cencora, Inc.ABC · Entity 2994 | Executive Vice President | April 04, 2018 | April 05, 2018 |
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cencora, Inc.
Report date April 04, 2018 · Filed April 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,989 |
Ending reported balance
After 2018-04-04 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2018-04-04 · Exercise / conversion · Acquired 1,200 · Balance 49,189 F1: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Row 2 · 2018-04-04 · Sale · Disposed 1,200 · Balance 47,989 F1: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Row 3 · 2018-04-04 · Exercise / conversion · Acquired 1,800 · Balance 49,789 F1: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Row 4 · 2018-04-04 · Sale · Disposed 1,800 · Balance 47,989 F1: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.37 · Expires 2019-03-01 | Direct | 4,800 |
Reported balance
After 2018-04-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-04-04 · Exercise / conversion · Disposed 1,200 · Balance 4,800 F1: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. F2: Exercisable in four equal annual installments on 03/01/13, 03/01/14, 03/01/15 and 03/01/2016 |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.21 · Expires 2019-11-14 | Direct | 7,200 |
Reported balance
After 2018-04-04 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-04-04 · Exercise / conversion · Disposed 1,800 · Balance 7,200 F1: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. F3: Exercisable in four equal annual installments on 11/14/13, 11/14/14, 11/14/15 and 11/14/16 |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020.
F2: Exercisable in four equal annual installments on 03/01/13, 03/01/14, 03/01/15 and 03/01/2016
F3: Exercisable in four equal annual installments on 11/14/13, 11/14/14, 11/14/15 and 11/14/16
TANDEM DIABETES CARE INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,836 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Exercise / conversion · Acquired 8,759 · Balance 29,836 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 10,220 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Grant · Acquired 10,220 · Balance 10,220 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Exercise / conversion · Disposed 8,759 · Balance 0 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.
F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 22, 2026 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000079 · wk-form4_1779480786.xml · derivative · entry 3 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3 · derivative.exercise_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. F3 · derivative.expiration_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000079 · wk-form4_1779480786.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 10,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000079 · wk-form4_1779480786.xml · derivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,220 Underlying: Common Stock · 10,220 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2 · derivative.exercise_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. F2 · derivative.expiration_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 4,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000105 · wk-form4_1748030594.xml · derivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,387 | $20.64 | $90,547.68 |
DisclosureSEC source: 0001438133-25-000105 · wk-form4_1748030594.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000105 · wk-form4_1748030594.xml · derivative · entry 3 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,759 Underlying: Common Stock · 8,759 shares Expires not disclosed F4 · security: Awarded on May 21, 2025 pursuant to the 2023 Plan. F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 24, 2024 Filed May 24, 2024 23:22 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 4,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000126 · wk-form4_1716592967.xml · derivative · entry 3 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded on May 24, 2023 pursuant to the 2023 Plan. F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 24, 2024 Filed May 24, 2024 23:22 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,434 | $51.73 | $229,370.82 |
DisclosureSEC source: 0001438133-24-000126 · wk-form4_1716592967.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2024 Filed May 24, 2024 23:22 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 4,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000126 · wk-form4_1716592967.xml · derivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,387 Underlying: Common Stock · 4,387 shares Expires not disclosed F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 21:16 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 949 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000157 · wk-form4_1691442986.xml · derivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 949 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on August 3, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · kind: This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.exercise_date: This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 21:16 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 949 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000157 · wk-form4_1691442986.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 2,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000106 · wf-form4_168513167473647.xml · derivative · entry 3 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,757 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F5 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F6 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. F6 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 2,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000106 · wf-form4_168513167473647.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRSU 2023 05 24 · Derivative | 4,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000106 · wf-form4_168513167473647.xml · derivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,434 Underlying: Common Stock · 4,434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 3,000 | $30.16 | $90,492.00 |
DisclosureSEC source: 0001438133-23-000090 · wf-form4_168452751088445.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,550 Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:33 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 949 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000183 · wf-form4_165973156033592.xml · derivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 949 Underlying: Common Stock · 949 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on August 3, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · kind: This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.exercise_date: This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:33 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 949 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000183 · wf-form4_165973156033592.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 2,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000115 · wf-form4_165370212629552.xml · derivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,757 Underlying: Common Stock · 2,757 shares Expires not disclosed F1 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 18, 2022 Filed May 20, 2022 00:02 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000097 · wf-form4_165300492583347.xml · derivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,653 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company. F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 18, 2022 Filed May 20, 2022 00:02 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000097 · wf-form4_165300492583347.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 483 | $74.58 | $36,022.14 |
DisclosureSEC source: 0001438133-22-000067 · wf-form4_165222139396227.xml · nonDerivative · entry 6 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,948 Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 500 | $75.00 | $37,500.00 |
DisclosureSEC source: 0001438133-22-000067 · wf-form4_165222139396227.xml · nonDerivative · entry 5 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,465 Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 400 | $75.21 | $30,084.00 |
DisclosureSEC source: 0001438133-22-000067 · wf-form4_165222139396227.xml · nonDerivative · entry 4 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,965 Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 500 | $74.60 | $37,300.00 |
DisclosureSEC source: 0001438133-22-000067 · wf-form4_165222139396227.xml · nonDerivative · entry 3 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,565 Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 17 | $74.57 | $1,267.61 |
DisclosureSEC source: 0001438133-22-000067 · wf-form4_165222139396227.xml · nonDerivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,065 Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 100 | $75.21 | $7,520.97 |
DisclosureSEC source: 0001438133-22-000067 · wf-form4_165222139396227.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048 Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 948 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000123 · wf-form4_162820056602947.xml · derivative · entry 2 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,898 Underlying: Common Stock · 948 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company. F3 · kind: This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 8/3/2021, and the remaining shares shall vest in two (2) equal annual installments thereafter. F4 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 8/3/2021, and the remaining shares shall vest in two (2) equal annual installments thereafter. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 948 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000123 · wf-form4_162820056602947.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:29 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 1,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000048 · wf-form4_162156055545539.xml · derivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,653 Underlying: Common Stock · 1,653 shares Expires not disclosed F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:22 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 2,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000127 · wf-form4_159658692079348.xml · derivative · entry 1 Howell Peyton R · CIK 0001528056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,846 Underlying: Common Stock · 2,846 shares Expires not disclosed F1 · security: Awarded on August 3, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| April 04, 2018 Filed Apr 5, 2018 20:29 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $40.21 | $0.00 |
DisclosureSEC source: 0001127602-18-014173 · form4.xml · derivative · entry 6 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Underlying: Common Stock · 1,800 shares Expires 2019-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. F3 · derivative.exercise_date: Exercisable in four equal annual installments on 11/14/13, 11/14/14, 11/14/15 and 11/14/16 Read SEC document |
| April 04, 2018 Filed Apr 5, 2018 20:29 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $37.37 | $0.00 |
DisclosureSEC source: 0001127602-18-014173 · form4.xml · derivative · entry 5 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 1,200 shares Expires 2019-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 03/01/13, 03/01/14, 03/01/15 and 03/01/2016 Read SEC document |
| April 04, 2018 Filed Apr 5, 2018 20:29 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 1,800 | $82.72 | $148,896.00 |
DisclosureSEC source: 0001127602-18-014173 · form4.xml · nonDerivative · entry 4 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,989 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| April 04, 2018 Filed Apr 5, 2018 20:29 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 1,800 | $40.21 | $72,378.00 |
DisclosureSEC source: 0001127602-18-014173 · form4.xml · nonDerivative · entry 3 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| April 04, 2018 Filed Apr 5, 2018 20:29 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 1,200 | $82.72 | $99,264.00 |
DisclosureSEC source: 0001127602-18-014173 · form4.xml · nonDerivative · entry 2 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,989 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| April 04, 2018 Filed Apr 5, 2018 20:29 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 1,200 | $37.37 | $44,844.00 |
DisclosureSEC source: 0001127602-18-014173 · form4.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $40.21 | $0.00 |
DisclosureSEC source: 0001127602-18-010706 · form4.xml · derivative · entry 6 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 1,800 shares Expires 2019-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. F3 · derivative.exercise_date: Exercisable in four equal annual installments on 11/14/13, 11/14/14, 11/14/15 and 11/14/16 Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $37.37 | $0.00 |
DisclosureSEC source: 0001127602-18-010706 · form4.xml · derivative · entry 5 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 1,200 shares Expires 2019-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 03/01/13, 03/01/14, 03/01/15 and 03/01/2016 Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 1,800 | $93.78 | $168,804.00 |
DisclosureSEC source: 0001127602-18-010706 · form4.xml · nonDerivative · entry 4 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,989 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 1,800 | $40.21 | $72,378.00 |
DisclosureSEC source: 0001127602-18-010706 · form4.xml · nonDerivative · entry 3 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 1,200 | $93.78 | $112,536.00 |
DisclosureSEC source: 0001127602-18-010706 · form4.xml · nonDerivative · entry 2 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,989 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 1,200 | $37.37 | $44,844.00 |
DisclosureSEC source: 0001127602-18-010706 · form4.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:12 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 17,851 | $0.00 Strike: $68.49 | $0.00 |
DisclosureSEC source: 0001127602-18-009649 · form4.xml · derivative · entry 3 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,851 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/14, 11/13/15, 11/13/16 and 11/13/17 Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:12 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 17,851 | $90.40 | $1,613,730.40 |
DisclosureSEC source: 0001127602-18-009649 · form4.xml · nonDerivative · entry 2 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,989 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:12 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 17,851 | $68.49 | $1,222,614.99 |
DisclosureSEC source: 0001127602-18-009649 · form4.xml · nonDerivative · entry 1 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| February 07, 2018 Filed Feb 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $40.21 | $0.00 |
DisclosureSEC source: 0001127602-18-004597 · form4.xml · derivative · entry 6 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,800 Underlying: Common Stock · 1,800 shares Expires 2019-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. F3 · derivative.exercise_date: Exercisable in four equal annual installments on 11/14/13, 11/14/14, 11/14/15 and 11/14/16 Read SEC document |
| February 07, 2018 Filed Feb 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $37.37 | $0.00 |
DisclosureSEC source: 0001127602-18-004597 · form4.xml · derivative · entry 5 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Underlying: Common Stock · 1,200 shares Expires 2019-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 03/01/13, 03/01/14, 03/01/15 and 03/01/2016 Read SEC document |
| February 07, 2018 Filed Feb 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 1,800 | $91.60 | $164,880.00 |
DisclosureSEC source: 0001127602-18-004597 · form4.xml · nonDerivative · entry 4 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,989 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| February 07, 2018 Filed Feb 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 1,800 | $40.21 | $72,378.00 |
DisclosureSEC source: 0001127602-18-004597 · form4.xml · nonDerivative · entry 3 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
| February 07, 2018 Filed Feb 8, 2018 21:06 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 1,200 | $91.60 | $109,920.00 |
DisclosureSEC source: 0001127602-18-004597 · form4.xml · nonDerivative · entry 2 Howell Peyton R · CIK 0001528056 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,989 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 21, 2017 governing stock options scheduled to expire on March 1, 2019 and November 13, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.